nodes	percent_of_prediction	percent_of_DWPC	metapath
Tazarotene—Pain of skin—Bleomycin—melanoma	0.0362	0.106	CcSEcCtD
Tazarotene—Localized exfoliation—Bleomycin—melanoma	0.0316	0.0925	CcSEcCtD
Tazarotene—Cheilitis—Dactinomycin—melanoma	0.0187	0.0547	CcSEcCtD
Tazarotene—Skin hyperpigmentation—Bleomycin—melanoma	0.0143	0.0419	CcSEcCtD
Tazarotene—Skin hyperpigmentation—Carmustine—melanoma	0.0125	0.0366	CcSEcCtD
Tazarotene—Burning sensation—Carmustine—melanoma	0.0107	0.0313	CcSEcCtD
Tazarotene—Dry skin—Vemurafenib—melanoma	0.00936	0.0274	CcSEcCtD
Tazarotene—Skin exfoliation—Bleomycin—melanoma	0.00813	0.0238	CcSEcCtD
Tazarotene—Photosensitivity reaction—Vemurafenib—melanoma	0.00805	0.0235	CcSEcCtD
Tazarotene—Skin hyperpigmentation—Docetaxel—melanoma	0.00804	0.0235	CcSEcCtD
Tazarotene—Skin exfoliation—Carmustine—melanoma	0.0071	0.0208	CcSEcCtD
Tazarotene—Oedema peripheral—Vemurafenib—melanoma	0.00696	0.0203	CcSEcCtD
Tazarotene—Burning sensation—Docetaxel—melanoma	0.00688	0.0201	CcSEcCtD
Tazarotene—Skin exfoliation—Temozolomide—melanoma	0.00686	0.0201	CcSEcCtD
Tazarotene—Erythema—Vemurafenib—melanoma	0.00615	0.018	CcSEcCtD
Tazarotene—Swelling—Carmustine—melanoma	0.00612	0.0179	CcSEcCtD
Tazarotene—Inflammation—Docetaxel—melanoma	0.00493	0.0144	CcSEcCtD
Tazarotene—Dry skin—Temozolomide—melanoma	0.00478	0.014	CcSEcCtD
Tazarotene—Skin exfoliation—Docetaxel—melanoma	0.00456	0.0133	CcSEcCtD
Tazarotene—Haemoglobin—Bleomycin—melanoma	0.0043	0.0126	CcSEcCtD
Tazarotene—Haemorrhage—Bleomycin—melanoma	0.00428	0.0125	CcSEcCtD
Tazarotene—Photosensitivity reaction—Temozolomide—melanoma	0.00412	0.012	CcSEcCtD
Tazarotene—Swelling—Docetaxel—melanoma	0.00393	0.0115	CcSEcCtD
Tazarotene—Haemoglobin—Carmustine—melanoma	0.00375	0.011	CcSEcCtD
Tazarotene—Haemorrhage—Carmustine—melanoma	0.00373	0.0109	CcSEcCtD
Tazarotene—Erythema—Bleomycin—melanoma	0.00372	0.0109	CcSEcCtD
Tazarotene—Oedema peripheral—Carmustine—melanoma	0.00368	0.0108	CcSEcCtD
Tazarotene—Dermatitis bullous—Docetaxel—melanoma	0.00363	0.0106	CcSEcCtD
Tazarotene—Haemoglobin—Temozolomide—melanoma	0.00363	0.0106	CcSEcCtD
Tazarotene—Haemorrhage—Temozolomide—melanoma	0.00361	0.0106	CcSEcCtD
Tazarotene—Oedema peripheral—Temozolomide—melanoma	0.00356	0.0104	CcSEcCtD
Tazarotene—Pruritus—Vemurafenib—melanoma	0.00355	0.0104	CcSEcCtD
Tazarotene—Erythema—Dactinomycin—melanoma	0.00347	0.0102	CcSEcCtD
Tazarotene—Erythema—Carmustine—melanoma	0.00325	0.00951	CcSEcCtD
Tazarotene—Dry skin—Docetaxel—melanoma	0.00318	0.0093	CcSEcCtD
Tazarotene—Rash—Vemurafenib—melanoma	0.00316	0.00925	CcSEcCtD
Tazarotene—Dermatitis—Vemurafenib—melanoma	0.00316	0.00924	CcSEcCtD
Tazarotene—Erythema—Temozolomide—melanoma	0.00314	0.00919	CcSEcCtD
Tazarotene—Discomfort—Bleomycin—melanoma	0.00313	0.00916	CcSEcCtD
Tazarotene—Oedema—Bleomycin—melanoma	0.00304	0.00889	CcSEcCtD
Tazarotene—Discomfort—Dactinomycin—melanoma	0.00292	0.00854	CcSEcCtD
Tazarotene—Oedema—Dactinomycin—melanoma	0.00284	0.00829	CcSEcCtD
Tazarotene—Oedema—Carmustine—melanoma	0.00265	0.00776	CcSEcCtD
Tazarotene—Discomfort—Temozolomide—melanoma	0.00264	0.00773	CcSEcCtD
Tazarotene—Pain—Bleomycin—melanoma	0.0026	0.0076	CcSEcCtD
Tazarotene—Oedema—Temozolomide—melanoma	0.00256	0.0075	CcSEcCtD
Tazarotene—Pain—Dactinomycin—melanoma	0.00242	0.00709	CcSEcCtD
Tazarotene—Haemoglobin—Docetaxel—melanoma	0.00241	0.00705	CcSEcCtD
Tazarotene—Haemorrhage—Docetaxel—melanoma	0.0024	0.00702	CcSEcCtD
Tazarotene—Oedema peripheral—Docetaxel—melanoma	0.00236	0.00691	CcSEcCtD
Tazarotene—Pain—Carmustine—melanoma	0.00227	0.00663	CcSEcCtD
Tazarotene—Pain—Temozolomide—melanoma	0.00219	0.00641	CcSEcCtD
Tazarotene—Pruritus—Bleomycin—melanoma	0.00215	0.00629	CcSEcCtD
Tazarotene—Erythema—Docetaxel—melanoma	0.00209	0.00611	CcSEcCtD
Tazarotene—RXRB—Vitamin A and Carotenoid Metabolism—MAPK1—melanoma	0.00208	0.00317	CbGpPWpGaD
Tazarotene—RARA—Adipogenesis—E2F1—melanoma	0.00208	0.00316	CbGpPWpGaD
Tazarotene—RARA—Gene Expression—CLNS1A—melanoma	0.00207	0.00314	CbGpPWpGaD
Tazarotene—RXRB—Gene Expression—CLNS1A—melanoma	0.00207	0.00314	CbGpPWpGaD
Tazarotene—RARB—Retinoic acid receptors-mediated signaling—AKT1—melanoma	0.00205	0.00312	CbGpPWpGaD
Tazarotene—RXRB—a6b1 and a6b4 Integrin signaling—EGFR—melanoma	0.00201	0.00305	CbGpPWpGaD
Tazarotene—RARA—Retinoic acid receptors-mediated signaling—AKT1—melanoma	0.00197	0.00299	CbGpPWpGaD
Tazarotene—RXRB—Retinoic acid receptors-mediated signaling—AKT1—melanoma	0.00197	0.00299	CbGpPWpGaD
Tazarotene—RARA—Adipogenesis—FAS—melanoma	0.00193	0.00293	CbGpPWpGaD
Tazarotene—Rash—Bleomycin—melanoma	0.00192	0.0056	CcSEcCtD
Tazarotene—Dermatitis—Bleomycin—melanoma	0.00191	0.0056	CcSEcCtD
Tazarotene—RARB—Generic Transcription Pathway—SKI—melanoma	0.00189	0.00287	CbGpPWpGaD
Tazarotene—CYP2C8—Biological oxidations—UGT2B10—melanoma	0.00183	0.00279	CbGpPWpGaD
Tazarotene—Pruritus—Temozolomide—melanoma	0.00181	0.0053	CcSEcCtD
Tazarotene—RARA—Adipogenesis—HIF1A—melanoma	0.00181	0.00276	CbGpPWpGaD
Tazarotene—RARA—Generic Transcription Pathway—SKI—melanoma	0.00181	0.00275	CbGpPWpGaD
Tazarotene—RXRB—Generic Transcription Pathway—SKI—melanoma	0.00181	0.00275	CbGpPWpGaD
Tazarotene—Rash—Dactinomycin—melanoma	0.00179	0.00523	CcSEcCtD
Tazarotene—RXRB—a6b1 and a6b4 Integrin signaling—PIK3CA—melanoma	0.00174	0.00265	CbGpPWpGaD
Tazarotene—RARB—Integrated Pancreatic Cancer Pathway—CDKN2B—melanoma	0.00174	0.00264	CbGpPWpGaD
Tazarotene—Oedema—Docetaxel—melanoma	0.00171	0.00499	CcSEcCtD
Tazarotene—RARB—Integrated Pancreatic Cancer Pathway—ABCB1—melanoma	0.0017	0.00258	CbGpPWpGaD
Tazarotene—Rash—Carmustine—melanoma	0.00167	0.00489	CcSEcCtD
Tazarotene—Dermatitis—Carmustine—melanoma	0.00167	0.00489	CcSEcCtD
Tazarotene—RARA—Integrated Pancreatic Cancer Pathway—CDKN2B—melanoma	0.00167	0.00253	CbGpPWpGaD
Tazarotene—RARG—Generic Transcription Pathway—NPPA—melanoma	0.00165	0.00251	CbGpPWpGaD
Tazarotene—RARB—Integrated Pancreatic Cancer Pathway—FGF1—melanoma	0.00163	0.00248	CbGpPWpGaD
Tazarotene—RARA—Integrated Pancreatic Cancer Pathway—ABCB1—melanoma	0.00163	0.00248	CbGpPWpGaD
Tazarotene—Rash—Temozolomide—melanoma	0.00162	0.00473	CcSEcCtD
Tazarotene—Dermatitis—Temozolomide—melanoma	0.00162	0.00472	CcSEcCtD
Tazarotene—RXRB—a6b1 and a6b4 Integrin signaling—HRAS—melanoma	0.00161	0.00245	CbGpPWpGaD
Tazarotene—RARB—Integrated Pancreatic Cancer Pathway—E2F1—melanoma	0.0016	0.00243	CbGpPWpGaD
Tazarotene—RARB—Integrated Pancreatic Cancer Pathway—PDGFRA—melanoma	0.00158	0.0024	CbGpPWpGaD
Tazarotene—RARA—Integrated Pancreatic Cancer Pathway—FGF1—melanoma	0.00156	0.00238	CbGpPWpGaD
Tazarotene—RARB—Integrated Pancreatic Cancer Pathway—PRKCA—melanoma	0.00156	0.00238	CbGpPWpGaD
Tazarotene—RARA—Adipogenesis—PPARG—melanoma	0.00154	0.00234	CbGpPWpGaD
Tazarotene—RARB—Integrated Pancreatic Cancer Pathway—FASLG—melanoma	0.00153	0.00233	CbGpPWpGaD
Tazarotene—RARA—Integrated Pancreatic Cancer Pathway—E2F1—melanoma	0.00153	0.00233	CbGpPWpGaD
Tazarotene—RARA—Integrated Pancreatic Cancer Pathway—PDGFRA—melanoma	0.00151	0.0023	CbGpPWpGaD
Tazarotene—RARB—Integrated Pancreatic Cancer Pathway—PCNA—melanoma	0.0015	0.00229	CbGpPWpGaD
Tazarotene—RARA—Integrated Pancreatic Cancer Pathway—PRKCA—melanoma	0.0015	0.00228	CbGpPWpGaD
Tazarotene—RARB—Generic Transcription Pathway—NPPA—melanoma	0.00148	0.00225	CbGpPWpGaD
Tazarotene—RARB—Integrated Pancreatic Cancer Pathway—FAS—melanoma	0.00148	0.00225	CbGpPWpGaD
Tazarotene—RARA—Adipogenesis—RB1—melanoma	0.00148	0.00224	CbGpPWpGaD
Tazarotene—RARA—Integrated Pancreatic Cancer Pathway—FASLG—melanoma	0.00147	0.00223	CbGpPWpGaD
Tazarotene—RARA—Adipogenesis—IGF1—melanoma	0.00146	0.00222	CbGpPWpGaD
Tazarotene—Pain—Docetaxel—melanoma	0.00146	0.00426	CcSEcCtD
Tazarotene—RARB—Integrated Pancreatic Cancer Pathway—RAC1—melanoma	0.00145	0.0022	CbGpPWpGaD
Tazarotene—RARA—Integrated Pancreatic Cancer Pathway—PCNA—melanoma	0.00144	0.00219	CbGpPWpGaD
Tazarotene—RXRB—a6b1 and a6b4 Integrin signaling—AKT1—melanoma	0.00142	0.00216	CbGpPWpGaD
Tazarotene—CYP2C8—Cytochrome P450 - arranged by substrate type—CYP17A1—melanoma	0.00142	0.00216	CbGpPWpGaD
Tazarotene—RARA—Generic Transcription Pathway—NPPA—melanoma	0.00142	0.00215	CbGpPWpGaD
Tazarotene—RXRB—Generic Transcription Pathway—NPPA—melanoma	0.00142	0.00215	CbGpPWpGaD
Tazarotene—RARA—Integrated Pancreatic Cancer Pathway—FAS—melanoma	0.00142	0.00215	CbGpPWpGaD
Tazarotene—CYP2C8—Oxidation by Cytochrome P450—CYP17A1—melanoma	0.0014	0.00213	CbGpPWpGaD
Tazarotene—RARA—Integrated Pancreatic Cancer Pathway—RAC1—melanoma	0.00139	0.00211	CbGpPWpGaD
Tazarotene—CYP2C8—Arachidonic acid metabolism—CYP1B1—melanoma	0.00138	0.0021	CbGpPWpGaD
Tazarotene—RARB—Integrated Pancreatic Cancer Pathway—CDK2—melanoma	0.00138	0.00209	CbGpPWpGaD
Tazarotene—RARA—Integrated Pancreatic Cancer Pathway—CDK2—melanoma	0.00132	0.00201	CbGpPWpGaD
Tazarotene—RARB—Integrated Pancreatic Cancer Pathway—ATM—melanoma	0.00131	0.00199	CbGpPWpGaD
Tazarotene—RARB—Integrated Pancreatic Cancer Pathway—CDK4—melanoma	0.0013	0.00198	CbGpPWpGaD
Tazarotene—RARA—Integrated Pancreatic Cancer Pathway—ATM—melanoma	0.00125	0.0019	CbGpPWpGaD
Tazarotene—RARA—Integrated Pancreatic Cancer Pathway—CDK4—melanoma	0.00125	0.0019	CbGpPWpGaD
Tazarotene—RARB—Integrated Pancreatic Cancer Pathway—APC—melanoma	0.00122	0.00186	CbGpPWpGaD
Tazarotene—RARB—Integrated Pancreatic Cancer Pathway—EGF—melanoma	0.00121	0.00184	CbGpPWpGaD
Tazarotene—Pruritus—Docetaxel—melanoma	0.00121	0.00353	CcSEcCtD
Tazarotene—CYP2C8—Cytochrome P450 - arranged by substrate type—CYP1B1—melanoma	0.00119	0.00181	CbGpPWpGaD
Tazarotene—CYP2C8—Oxidation by Cytochrome P450—CYP1B1—melanoma	0.00118	0.00179	CbGpPWpGaD
Tazarotene—RARA—Integrated Pancreatic Cancer Pathway—APC—melanoma	0.00117	0.00178	CbGpPWpGaD
Tazarotene—CYP2C8—Metapathway biotransformation—AKR1B10—melanoma	0.00117	0.00177	CbGpPWpGaD
Tazarotene—RARA—Integrated Pancreatic Cancer Pathway—EGF—melanoma	0.00116	0.00176	CbGpPWpGaD
Tazarotene—CYP2C8—Phase 1 - Functionalization of compounds—CYP17A1—melanoma	0.00115	0.00175	CbGpPWpGaD
Tazarotene—RARB—Integrated Pancreatic Cancer Pathway—CASP8—melanoma	0.00114	0.00173	CbGpPWpGaD
Tazarotene—RARB—Integrated Pancreatic Cancer Pathway—IGF1—melanoma	0.00112	0.0017	CbGpPWpGaD
Tazarotene—RARA—Integrated Pancreatic Cancer Pathway—CASP8—melanoma	0.00109	0.00166	CbGpPWpGaD
Tazarotene—RARA—Adipogenesis—CTNNB1—melanoma	0.00109	0.00165	CbGpPWpGaD
Tazarotene—RARB—Integrated Pancreatic Cancer Pathway—MAP2K1—melanoma	0.00108	0.00165	CbGpPWpGaD
Tazarotene—Rash—Docetaxel—melanoma	0.00108	0.00314	CcSEcCtD
Tazarotene—RARA—Integrated Pancreatic Cancer Pathway—IGF1—melanoma	0.00107	0.00163	CbGpPWpGaD
Tazarotene—Dermatitis—Docetaxel—melanoma	0.00107	0.00314	CcSEcCtD
Tazarotene—RARA—Adipogenesis—CDKN1A—melanoma	0.00106	0.00161	CbGpPWpGaD
Tazarotene—RARA—Integrated Pancreatic Cancer Pathway—MAP2K1—melanoma	0.00104	0.00158	CbGpPWpGaD
Tazarotene—RARB—Integrated Pancreatic Cancer Pathway—FGF2—melanoma	0.00103	0.00157	CbGpPWpGaD
Tazarotene—RARG—Gene Expression—RPS3—melanoma	0.00103	0.00157	CbGpPWpGaD
Tazarotene—RARG—Gene Expression—SNRPE—melanoma	0.00101	0.00154	CbGpPWpGaD
Tazarotene—RARG—Gene Expression—SKI—melanoma	0.00101	0.00154	CbGpPWpGaD
Tazarotene—RARA—Integrated Pancreatic Cancer Pathway—FGF2—melanoma	0.000988	0.0015	CbGpPWpGaD
Tazarotene—RARB—Integrated Pancreatic Cancer Pathway—BCL2—melanoma	0.000979	0.00149	CbGpPWpGaD
Tazarotene—CYP2C8—Phase 1 - Functionalization of compounds—CYP1B1—melanoma	0.000968	0.00147	CbGpPWpGaD
Tazarotene—RARB—Integrated Pancreatic Cancer Pathway—MDM2—melanoma	0.000964	0.00147	CbGpPWpGaD
Tazarotene—RARG—Generic Transcription Pathway—CDKN2B—melanoma	0.000963	0.00146	CbGpPWpGaD
Tazarotene—RARB—Integrated Pancreatic Cancer Pathway—ERBB2—melanoma	0.000951	0.00145	CbGpPWpGaD
Tazarotene—RARA—Adipogenesis—STAT3—melanoma	0.000946	0.00144	CbGpPWpGaD
Tazarotene—RARG—Generic Transcription Pathway—VDR—melanoma	0.000939	0.00143	CbGpPWpGaD
Tazarotene—RARA—Integrated Pancreatic Cancer Pathway—BCL2—melanoma	0.000938	0.00143	CbGpPWpGaD
Tazarotene—RARB—Integrated Pancreatic Cancer Pathway—PTGS2—melanoma	0.00093	0.00141	CbGpPWpGaD
Tazarotene—RARA—Integrated Pancreatic Cancer Pathway—MDM2—melanoma	0.000925	0.00141	CbGpPWpGaD
Tazarotene—RARB—Gene Expression—RPS3—melanoma	0.000924	0.0014	CbGpPWpGaD
Tazarotene—RARA—Integrated Pancreatic Cancer Pathway—ERBB2—melanoma	0.000912	0.00139	CbGpPWpGaD
Tazarotene—RARB—Gene Expression—SNRPE—melanoma	0.00091	0.00138	CbGpPWpGaD
Tazarotene—RARB—Gene Expression—SKI—melanoma	0.00091	0.00138	CbGpPWpGaD
Tazarotene—RARA—Integrated Pancreatic Cancer Pathway—PTGS2—melanoma	0.000891	0.00135	CbGpPWpGaD
Tazarotene—RARA—Gene Expression—RPS3—melanoma	0.000886	0.00135	CbGpPWpGaD
Tazarotene—RXRB—Gene Expression—RPS3—melanoma	0.000886	0.00135	CbGpPWpGaD
Tazarotene—RARB—Integrated Pancreatic Cancer Pathway—CDKN1B—melanoma	0.000881	0.00134	CbGpPWpGaD
Tazarotene—RARA—Gene Expression—SKI—melanoma	0.000872	0.00133	CbGpPWpGaD
Tazarotene—RXRB—Gene Expression—SNRPE—melanoma	0.000872	0.00133	CbGpPWpGaD
Tazarotene—RARA—Gene Expression—SNRPE—melanoma	0.000872	0.00133	CbGpPWpGaD
Tazarotene—RXRB—Gene Expression—SKI—melanoma	0.000872	0.00133	CbGpPWpGaD
Tazarotene—RARB—Generic Transcription Pathway—CDKN2B—melanoma	0.000864	0.00131	CbGpPWpGaD
Tazarotene—RARB—Integrated Pancreatic Cancer Pathway—CASP3—melanoma	0.000863	0.00131	CbGpPWpGaD
Tazarotene—RARA—Integrated Pancreatic Cancer Pathway—CDKN1B—melanoma	0.000844	0.00128	CbGpPWpGaD
Tazarotene—RARB—Generic Transcription Pathway—VDR—melanoma	0.000842	0.00128	CbGpPWpGaD
Tazarotene—RARB—Integrated Pancreatic Cancer Pathway—CCND1—melanoma	0.00084	0.00128	CbGpPWpGaD
Tazarotene—RARB—Integrated Pancreatic Cancer Pathway—CTNNB1—melanoma	0.000832	0.00126	CbGpPWpGaD
Tazarotene—RARA—Generic Transcription Pathway—CDKN2B—melanoma	0.000828	0.00126	CbGpPWpGaD
Tazarotene—RXRB—Generic Transcription Pathway—CDKN2B—melanoma	0.000828	0.00126	CbGpPWpGaD
Tazarotene—RARA—Integrated Pancreatic Cancer Pathway—CASP3—melanoma	0.000827	0.00126	CbGpPWpGaD
Tazarotene—RARA—Adipogenesis—TNF—melanoma	0.000819	0.00124	CbGpPWpGaD
Tazarotene—RARB—Integrated Pancreatic Cancer Pathway—CDKN1A—melanoma	0.000813	0.00124	CbGpPWpGaD
Tazarotene—RARB—Integrated Pancreatic Cancer Pathway—PTEN—melanoma	0.000811	0.00123	CbGpPWpGaD
Tazarotene—RARA—Generic Transcription Pathway—VDR—melanoma	0.000807	0.00123	CbGpPWpGaD
Tazarotene—RXRB—Generic Transcription Pathway—VDR—melanoma	0.000807	0.00123	CbGpPWpGaD
Tazarotene—RARB—Integrated Pancreatic Cancer Pathway—NFKB1—melanoma	0.000807	0.00123	CbGpPWpGaD
Tazarotene—RARA—Integrated Pancreatic Cancer Pathway—CCND1—melanoma	0.000805	0.00122	CbGpPWpGaD
Tazarotene—RARA—Integrated Pancreatic Cancer Pathway—CTNNB1—melanoma	0.000798	0.00121	CbGpPWpGaD
Tazarotene—RARG—Gene Expression—NPPA—melanoma	0.000794	0.00121	CbGpPWpGaD
Tazarotene—RARA—Integrated Pancreatic Cancer Pathway—CDKN1A—melanoma	0.000779	0.00118	CbGpPWpGaD
Tazarotene—RARA—Integrated Pancreatic Cancer Pathway—PTEN—melanoma	0.000777	0.00118	CbGpPWpGaD
Tazarotene—RARA—Integrated Pancreatic Cancer Pathway—NFKB1—melanoma	0.000774	0.00118	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism of lipids and lipoproteins—ACER3—melanoma	0.00077	0.00117	CbGpPWpGaD
Tazarotene—RARB—Integrated Pancreatic Cancer Pathway—VEGFA—melanoma	0.000732	0.00111	CbGpPWpGaD
Tazarotene—RARB—Gene Expression—NPPA—melanoma	0.000712	0.00108	CbGpPWpGaD
Tazarotene—RARA—Integrated Pancreatic Cancer Pathway—VEGFA—melanoma	0.000702	0.00107	CbGpPWpGaD
Tazarotene—RARG—Generic Transcription Pathway—NOTCH1—melanoma	0.000694	0.00105	CbGpPWpGaD
Tazarotene—RARB—Integrated Pancreatic Cancer Pathway—MAPK3—melanoma	0.000693	0.00105	CbGpPWpGaD
Tazarotene—RXRB—Gene Expression—NPPA—melanoma	0.000682	0.00104	CbGpPWpGaD
Tazarotene—RARA—Gene Expression—NPPA—melanoma	0.000682	0.00104	CbGpPWpGaD
Tazarotene—RARB—Integrated Pancreatic Cancer Pathway—MYC—melanoma	0.000674	0.00102	CbGpPWpGaD
Tazarotene—RARA—Integrated Pancreatic Cancer Pathway—MAPK3—melanoma	0.000664	0.00101	CbGpPWpGaD
Tazarotene—RARA—Adipogenesis—IL6—melanoma	0.000661	0.001	CbGpPWpGaD
Tazarotene—RARB—Integrated Pancreatic Cancer Pathway—MAPK1—melanoma	0.000659	0.001	CbGpPWpGaD
Tazarotene—RARB—Integrated Pancreatic Cancer Pathway—EGFR—melanoma	0.000659	0.001	CbGpPWpGaD
Tazarotene—RARG—Generic Transcription Pathway—PPARG—melanoma	0.000655	0.000995	CbGpPWpGaD
Tazarotene—RARA—Integrated Pancreatic Cancer Pathway—MYC—melanoma	0.000646	0.000982	CbGpPWpGaD
Tazarotene—RARA—Integrated Pancreatic Cancer Pathway—MAPK1—melanoma	0.000632	0.000961	CbGpPWpGaD
Tazarotene—RARA—Integrated Pancreatic Cancer Pathway—EGFR—melanoma	0.000632	0.00096	CbGpPWpGaD
Tazarotene—RARB—Integrated Pancreatic Cancer Pathway—TNF—melanoma	0.000628	0.000954	CbGpPWpGaD
Tazarotene—CYP2C8—Arachidonic acid metabolism—PTGS2—melanoma	0.000623	0.000946	CbGpPWpGaD
Tazarotene—RARB—Integrated Pancreatic Cancer Pathway—KRAS—melanoma	0.000623	0.000946	CbGpPWpGaD
Tazarotene—RARB—Generic Transcription Pathway—NOTCH1—melanoma	0.000622	0.000945	CbGpPWpGaD
Tazarotene—CYP2C8—Biological oxidations—CYP17A1—melanoma	0.000611	0.000928	CbGpPWpGaD
Tazarotene—CYP2C8—Metapathway biotransformation—CYP17A1—melanoma	0.000602	0.000916	CbGpPWpGaD
Tazarotene—RARA—Integrated Pancreatic Cancer Pathway—TNF—melanoma	0.000602	0.000915	CbGpPWpGaD
Tazarotene—RARA—Integrated Pancreatic Cancer Pathway—KRAS—melanoma	0.000597	0.000907	CbGpPWpGaD
Tazarotene—RARA—Generic Transcription Pathway—NOTCH1—melanoma	0.000596	0.000906	CbGpPWpGaD
Tazarotene—RXRB—Generic Transcription Pathway—NOTCH1—melanoma	0.000596	0.000906	CbGpPWpGaD
Tazarotene—RARB—Generic Transcription Pathway—PPARG—melanoma	0.000587	0.000892	CbGpPWpGaD
Tazarotene—RARG—Gene Expression—HDAC2—melanoma	0.00058	0.000882	CbGpPWpGaD
Tazarotene—RARB—Integrated Pancreatic Cancer Pathway—PIK3CA—melanoma	0.000572	0.000869	CbGpPWpGaD
Tazarotene—RARA—Generic Transcription Pathway—PPARG—melanoma	0.000563	0.000855	CbGpPWpGaD
Tazarotene—RXRB—Generic Transcription Pathway—PPARG—melanoma	0.000563	0.000855	CbGpPWpGaD
Tazarotene—RARB—Integrated Pancreatic Cancer Pathway—TP53—melanoma	0.000553	0.000841	CbGpPWpGaD
Tazarotene—RARA—Integrated Pancreatic Cancer Pathway—PIK3CA—melanoma	0.000548	0.000833	CbGpPWpGaD
Tazarotene—RARA—Integrated Pancreatic Cancer Pathway—TP53—melanoma	0.000531	0.000806	CbGpPWpGaD
Tazarotene—RARB—Gene Expression—HDAC2—melanoma	0.00052	0.000791	CbGpPWpGaD
Tazarotene—CYP2C8—Biological oxidations—CYP1B1—melanoma	0.000514	0.000781	CbGpPWpGaD
Tazarotene—CYP2C8—Metapathway biotransformation—CYP1B1—melanoma	0.000507	0.000771	CbGpPWpGaD
Tazarotene—RARA—Gene Expression—HDAC2—melanoma	0.000499	0.000758	CbGpPWpGaD
Tazarotene—RXRB—Gene Expression—HDAC2—melanoma	0.000499	0.000758	CbGpPWpGaD
Tazarotene—RARB—Integrated Pancreatic Cancer Pathway—AKT1—melanoma	0.000467	0.00071	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism of lipids and lipoproteins—PIP4K2A—melanoma	0.000466	0.000709	CbGpPWpGaD
Tazarotene—RARG—Gene Expression—CDKN2B—melanoma	0.000464	0.000705	CbGpPWpGaD
Tazarotene—RARG—Gene Expression—VDR—melanoma	0.000452	0.000687	CbGpPWpGaD
Tazarotene—RARA—Integrated Pancreatic Cancer Pathway—AKT1—melanoma	0.000448	0.000681	CbGpPWpGaD
Tazarotene—RARG—Gene Expression—PRKCA—melanoma	0.000417	0.000634	CbGpPWpGaD
Tazarotene—RARB—Gene Expression—CDKN2B—melanoma	0.000416	0.000632	CbGpPWpGaD
Tazarotene—RARG—Gene Expression—ERCC2—melanoma	0.000413	0.000628	CbGpPWpGaD
Tazarotene—RARB—Gene Expression—VDR—melanoma	0.000405	0.000616	CbGpPWpGaD
Tazarotene—RARA—Gene Expression—CDKN2B—melanoma	0.000399	0.000606	CbGpPWpGaD
Tazarotene—RXRB—Gene Expression—CDKN2B—melanoma	0.000399	0.000606	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism of lipids and lipoproteins—CUBN—melanoma	0.000389	0.000591	CbGpPWpGaD
Tazarotene—RXRB—Gene Expression—VDR—melanoma	0.000389	0.000591	CbGpPWpGaD
Tazarotene—RARA—Gene Expression—VDR—melanoma	0.000389	0.000591	CbGpPWpGaD
Tazarotene—RARB—Gene Expression—PRKCA—melanoma	0.000374	0.000568	CbGpPWpGaD
Tazarotene—RARG—Generic Transcription Pathway—MYC—melanoma	0.000373	0.000567	CbGpPWpGaD
Tazarotene—RARB—Gene Expression—ERCC2—melanoma	0.000371	0.000564	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism of lipids and lipoproteins—GPAM—melanoma	0.000364	0.000553	CbGpPWpGaD
Tazarotene—RXRB—Gene Expression—PRKCA—melanoma	0.000358	0.000545	CbGpPWpGaD
Tazarotene—RARA—Gene Expression—PRKCA—melanoma	0.000358	0.000545	CbGpPWpGaD
Tazarotene—RARA—Gene Expression—ERCC2—melanoma	0.000356	0.00054	CbGpPWpGaD
Tazarotene—RXRB—Gene Expression—ERCC2—melanoma	0.000356	0.00054	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—ACER3—melanoma	0.000343	0.000521	CbGpPWpGaD
Tazarotene—RARB—Generic Transcription Pathway—MYC—melanoma	0.000335	0.000509	CbGpPWpGaD
Tazarotene—RARG—Gene Expression—NOTCH1—melanoma	0.000334	0.000507	CbGpPWpGaD
Tazarotene—RARA—Generic Transcription Pathway—MYC—melanoma	0.000321	0.000488	CbGpPWpGaD
Tazarotene—RXRB—Generic Transcription Pathway—MYC—melanoma	0.000321	0.000488	CbGpPWpGaD
Tazarotene—RARG—Gene Expression—PPARG—melanoma	0.000315	0.000479	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—UGT2B10—melanoma	0.000313	0.000476	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism of lipids and lipoproteins—PLA2G6—melanoma	0.00031	0.00047	CbGpPWpGaD
Tazarotene—RARB—Gene Expression—NOTCH1—melanoma	0.000299	0.000455	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—HS3ST5—melanoma	0.000291	0.000443	CbGpPWpGaD
Tazarotene—RARA—Gene Expression—NOTCH1—melanoma	0.000287	0.000436	CbGpPWpGaD
Tazarotene—RXRB—Gene Expression—NOTCH1—melanoma	0.000287	0.000436	CbGpPWpGaD
Tazarotene—RARB—Gene Expression—PPARG—melanoma	0.000283	0.00043	CbGpPWpGaD
Tazarotene—RXRB—Gene Expression—PPARG—melanoma	0.000271	0.000412	CbGpPWpGaD
Tazarotene—RARA—Gene Expression—PPARG—melanoma	0.000271	0.000412	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism of lipids and lipoproteins—CYP17A1—melanoma	0.000235	0.000356	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—PLCB4—melanoma	0.000221	0.000336	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism of lipids and lipoproteins—FASN—melanoma	0.000217	0.000329	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—SLC6A11—melanoma	0.000208	0.000316	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—PIP4K2A—melanoma	0.000208	0.000316	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—MTAP—melanoma	0.000202	0.000307	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism of lipids and lipoproteins—CYP1B1—melanoma	0.000197	0.0003	CbGpPWpGaD
Tazarotene—RARG—Gene Expression—MAPK3—melanoma	0.000185	0.000281	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—PHGDH—melanoma	0.00018	0.000274	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—LUM—melanoma	0.00018	0.000274	CbGpPWpGaD
Tazarotene—RARG—Gene Expression—MYC—melanoma	0.00018	0.000273	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—HPSE—melanoma	0.000177	0.000268	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—CUBN—melanoma	0.000173	0.000263	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—SDHD—melanoma	0.000167	0.000254	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—BSG—melanoma	0.000167	0.000254	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—CSPG4—melanoma	0.000167	0.000254	CbGpPWpGaD
Tazarotene—RARB—Gene Expression—MAPK3—melanoma	0.000166	0.000252	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—GPAM—melanoma	0.000162	0.000246	CbGpPWpGaD
Tazarotene—RARB—Gene Expression—MYC—melanoma	0.000161	0.000245	CbGpPWpGaD
Tazarotene—RARA—Gene Expression—MAPK3—melanoma	0.000159	0.000241	CbGpPWpGaD
Tazarotene—RXRB—Gene Expression—MAPK3—melanoma	0.000159	0.000241	CbGpPWpGaD
Tazarotene—RXRB—Gene Expression—MYC—melanoma	0.000155	0.000235	CbGpPWpGaD
Tazarotene—RARA—Gene Expression—MYC—melanoma	0.000155	0.000235	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—PLA2G6—melanoma	0.000138	0.000209	CbGpPWpGaD
Tazarotene—RARG—Gene Expression—AKT1—melanoma	0.000125	0.000189	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—VCAN—melanoma	0.000124	0.000188	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CG—melanoma	0.000117	0.000178	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—melanoma	0.000113	0.000172	CbGpPWpGaD
Tazarotene—RARB—Gene Expression—AKT1—melanoma	0.000112	0.00017	CbGpPWpGaD
Tazarotene—RARA—Gene Expression—AKT1—melanoma	0.000107	0.000163	CbGpPWpGaD
Tazarotene—RXRB—Gene Expression—AKT1—melanoma	0.000107	0.000163	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—CYP17A1—melanoma	0.000104	0.000159	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CD—melanoma	0.000103	0.000157	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism of lipids and lipoproteins—ALB—melanoma	0.000102	0.000155	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—GNA11—melanoma	9.87e-05	0.00015	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—FASN—melanoma	9.65e-05	0.000147	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—SLC5A5—melanoma	9.5e-05	0.000144	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—CD44—melanoma	9.17e-05	0.000139	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—GNAQ—melanoma	9.17e-05	0.000139	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CB—melanoma	8.98e-05	0.000136	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—melanoma	8.9e-05	0.000135	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—CYP1B1—melanoma	8.79e-05	0.000134	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—melanoma	7.76e-05	0.000118	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—ABCB1—melanoma	7.24e-05	0.00011	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—PRKCA—melanoma	6.66e-05	0.000101	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—ERCC2—melanoma	6.61e-05	0.0001	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	5.47e-05	8.32e-05	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—PIK3CG—melanoma	5.22e-05	7.93e-05	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—PPARG—melanoma	5.04e-05	7.66e-05	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—PIK3CD—melanoma	4.59e-05	6.97e-05	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—ALB—melanoma	4.53e-05	6.88e-05	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—PIK3CB—melanoma	4e-05	6.08e-05	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—PTGS2—melanoma	3.96e-05	6.02e-05	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—PTEN—melanoma	3.46e-05	5.25e-05	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—PIK3CA—melanoma	2.44e-05	3.71e-05	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—AKT1—melanoma	1.99e-05	3.03e-05	CbGpPWpGaD
